Journal of Drug Targeting

Papers
(The TQCC of Journal of Drug Targeting is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
A comprehensive review on the antiviral activities of chalcones63
Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances58
CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia57
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects55
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease37
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances36
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-1932
Improved oral delivery of quercetin with hyaluronic acid containing niosomes as a promising formulation32
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics32
Targetting ferroptosis for blood cell-related diseases31
3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status30
ABC transporters in breast cancer: their roles in multidrug resistance and beyond30
Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications30
Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications28
The relevant targets of anti-oxidative stress: a review28
Fabrication and characterisation of self-applicating heparin sodium microneedle patches27
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide26
Current status of micro/nanomotors in drug delivery26
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety26
Active-site molecular docking of nigellidine with nucleocapsid–NSP2–MPro of COVID-19 and to human IL1R–IL6R and strong antioxidant role of Nigella sativa in experimental rats25
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway24
Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis24
Niosomal formulation for antibacterial applications24
Potential inhibitors of SARS-CoV-2: recent advances24
Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation23
Mitochondria autophagy: a potential target for cancer therapy22
A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application22
An updated review on exosomes: biosynthesis to clinical applications21
New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies21
Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells20
Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery20
MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson’s disease19
Mitochondrial delivery of microRNA mimic let-7b to NSCLC cells by PAMAM-based nanoparticles19
Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer’s disease19
PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery18
Methods for fabricating oxygen releasing biomaterials18
Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway18
Nanoliposomes as drug delivery systems: safety concerns18
Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities17
Biomedical application of chondroitin sulfate with nanoparticles in drug delivery systems: systematic review17
A novel progress of drug delivery system for organelle targeting in tumour cells17
Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer17
The role of peptide-based therapeutics in oncotherapy16
Mesencephalic astrocyte-derived neurotrophic factor restores blood–brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway16
EGFR and anti-EGFR nanobodies: review and update15
Micro and nanorobot-based drug delivery: an overview15
Immunotoxins and nanobody-based immunotoxins: review and update15
Progress in tumour-targeted drug delivery based on cell-penetrating peptides15
Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism15
A mechanistic perspective on targeting bacterial drug resistance with nanoparticles15
The mechanisms of lncRNA GAS5 in cardiovascular cells and its potential as novel therapeutic target15
Iron metabolism in Pseudomonas aeruginosa biofilm and the involved iron-targeted anti-biofilm strategies15
HSP60 in cancer: a promising biomarker for diagnosis and a potentially useful target for treatment15
Targeting PRAS40: a novel therapeutic strategy for human diseases15
Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer15
Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver14
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide14
Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac)14
MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor α expression14
Inhibition of microRNA-10b-5p up-regulates HOXD10 to attenuate Alzheimer’s disease in rats via the Rho/ROCK signalling pathway14
TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy14
Enzyme-instructed self-assembly of the stereoisomers of pentapeptides to form biocompatible supramolecular hydrogels13
Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo13
New generation of viral nanoparticles for targeted drug delivery in cancer therapy13
Exosome vesicle as a nano-therapeutic carrier for breast cancer13
Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases13
Non-ionic surfactant vesicles as a carrier system for dermal delivery of (+)-Catechin and their antioxidant effects13
Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases13
Light mediated drug delivery systems: a review12
Envelope proteins as antiviral drug target12
Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment12
Functionality of receptor targeted zinc-insulin quantum clusters in skin tissue augmentation and bioimaging12
Hyaluronic acid-coated metal-organic frameworks benefit the ROS-mediated apoptosis and amplified anticancer activity of artesunate12
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection12
Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease12
Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis12
Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art12
Mycobacterial ethambutol responsive genes and implications in antibiotics resistance12
Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy11
Sirtuins as therapeutic targets for improving delayed wound healing in diabetes11
Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer11
Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth11
ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, targeted delivery of dexamethasone to arthritic joints11
Engineered anti-EGFRvIII targeted exosomes induce apoptosis in glioblastoma multiforme11
A pH-Driven indomethacin-loaded nanomedicine for effective rheumatoid arthritis therapy by combining with photothermal therapy11
Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis11
0.030450820922852